In the Republic of Korea, Ocrevus (ocrelizumab) treatment typically costs from AUD $26,293 to AUD $33,805. Prices primarily depend on the infusion method and required diagnostic testing. Australian patients often save around 0% compared to local private costs of AUD $18,636 on average. The total price generally covers the medication, nursing supervision, and the clinical facility fee.
Bookimed Expert Insight: Choosing major Seoul centres like Severance Hospital offers significant value for Australians. These facilities hold Joint Commission International (JCI) accreditation and serve millions of patients annually. This massive scale often results in highly efficient infusion protocols. Patients should note that tertiary hospitals in Seoul provide access to multidisciplinary teams within smart-building environments for better monitoring.
| Republic of Korea | Thailand | Turkey | |
| Ocrevus (ocrelizumab) | from AUD $26,293 | from AUD $28,893 | from AUD $14,447 |
No hidden fees – just official clinic prices. Pay at the clinic for Ocrevus (ocrelizumab) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ocrevus (ocrelizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ocrevus (ocrelizumab) journey.